Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 3 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 2 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 3 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 2 5 IN PLASTIC CONTAINER.
DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
DIANEAL LOW CALCIUM W/DEXTROSE 3.5% provides a hyperosmotic solution for peritoneal dialysis. Dextrose generates an osmotic gradient across the peritoneal membrane, promoting fluid and solute removal (ultrafiltration). Low calcium content helps manage hypercalcemia in patients requiring peritoneal dialysis.
Dianeal PD-2 with Dextrose 2.5% is a peritoneal dialysis solution that removes waste products and excess fluid from the blood via diffusion and ultrafiltration across the peritoneal membrane. Dextrose creates an osmotic gradient driving fluid removal; electrolytes (sodium, chloride, calcium, magnesium, lactate) correct electrolyte imbalances.
Intraperitoneal: 2-3 L per exchange, 4-5 exchanges daily, as prescribed by physician based on body size and residual renal function.
Intraperitoneal administration: 2 to 2.5 liters per exchange, typically 4 exchanges per day, with dwell times of 4-6 hours during the day and 8-12 hours overnight. Concentration selected based on ultrafiltration needs.
None Documented
None Documented
Not applicable; drug is not systematically absorbed. Dextrose has half-life of ~1.5-2 hours after absorption.
Not applicable; drug is not systemically absorbed. The peritoneal clearance of glucose follows first-order kinetics with a half-life of approximately 2-3 hours in the peritoneal cavity.
Primarily removed via peritoneal dialysis; negligible renal excretion due to local administration. Dextrose is metabolized systemically; dialysate is drained as waste.
Renal: negligible; drug is not absorbed systemically. The glucose is metabolized locally in peritoneal cavity and removed with dialysate outflow.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution